Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Oxaliplatin
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Oxaliplatin
Malignant disease and immunosuppression, Platinum compounds, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Oxaliplatin
Oxaliplatin [Specialist Drug]
Malignant Disease, Cytotoxic Responsive Malignancy, Antineoplastic Drugs Platinum Compounds
Links found
NICE TA100: Colon cancer (adjuvant) - capecitabine and oxaliplatin
NICE TA1113: Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory diffuse large B-cell lymphoma
NICE TA212: Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer
NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy